Back to Search Start Over

Supplementary Tables from Impact of Neoadjuvant Durvalumab with or without Tremelimumab on CD8+ Tumor Lymphocyte Density, Safety, and Efficacy in Patients with Oropharynx Cancer: CIAO Trial Results

Details

Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....93723b3a5978f3375277dafce6127683
Full Text :
https://doi.org/10.1158/1078-0432.22477680.v1